Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Caoili · SciRah

Researcher profile · Semantic Scholar

J. Caoili

Share profile

J. Caoili — researcher profile on SciRah

h-index: 11
Works: 16
Citations: 1,095

Most-cited papers

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Tracy L. Dalton, P. Cegielski, S. Akksilp, L. Asencios +16 more
2012The Lancet222 citations Open access
Semantic Scholar
Evaluation of sputum culture conversion as a prognostic marker for end-of-treatment outcome inpatients with multidrug-resistant tuberculosis
E. Kurbatova, J. Cegielski, C. Lienhardt, Rattanawadee Akksilp +32 more
2015The Lancet Respiratory Medicine151 citations Open access
Semantic Scholar
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.
J. Cegielski, Tracy L. Dalton, Martin J. A. Yagui, Wanpen Wattanaamornkiet +77 more
2014Clinical Infectious Diseases144 citations Open access
Semantic Scholar
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study
Aditya Sharma, A. Hill, E. Kurbatova, M. L. van der Walt +19 more
2017Lancet. Infectious Diseases (Print)140 citations Open access
Semantic Scholar
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
F. vonGroote-Bidlingmaier, R. Patientia, E. Sánchez, V. Balanag +19 more
2019The Lancet Respiratory Medicine121 citations Open access
Semantic Scholar
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
J. Cegielski, E. Kurbatova, M. L. van der Walt, J. Brand +72 more
2015Clinical Infectious Diseases105 citations Open access
Semantic Scholar
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
C. Tweed, G. Wills, A. Crook, E. Amukoye +35 more
2021The International Journal of Tuberculosis and Lung Disease55 citations Open access
Semantic Scholar
Weight gain and response to treatment for multidrug-resistant tuberculosis.
M. T. Gler, R. Guilatco, J. Caoili, J. Ershova +2 more
2013American Journal of Tropical Medicine and Hygiene45 citations Open access
Semantic Scholar
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study
C. Yuen, E. Kurbatova, T. Tupasi, J. Caoili +18 more
2015PLoS Medicine43 citations Open access
Semantic Scholar
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
M. Cevik, Lindsay C Thompson, C. Upton, V. Rolla +32 more
2024Lancet. Infectious Diseases (Print)39 citations Open access
Semantic Scholar
Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries
E. Kurbatova, Tracy L. Dalton, J. Ershova, T. Tupasi +16 more
2015Emerging Infectious Diseases18 citations Open access
Semantic Scholar
Design and implementation of an HIV/AIDS electronic medical record system (HIV/AIDS EMR) in the Philippines.
G. Zabat, J. Caoili, Albert D. Anduyon, G. J. Ramos +5 more
2007AMIA ... Annual Symposium proceedings. AMIA Symposium7 citations
Semantic Scholar
Fit testing of KN95 masks
J. Caoili, A. Vega, S. Santos, Jomar Bigalbal +1 more
2020International Journal of Infection Control3 citations Open access
Semantic Scholar
Evaluation of sputum culture conversion as a prognostic marker for end-of-treatment outcome inpatients with multidrug-resistant tuberculosis
E. Kurbatova, J. Cegielski, C. Lienhardt, Rattanawadee Akksilp +32 more
3 citations
Semantic Scholar
Resistance to second-line drugs in multidrug-resistant tuberculosis - Authors' reply.
Tracy L. Dalton, P. Cegielski, E. Kurbatova, J. Ershova +1 more
2013The Lancet2 citations Open access
Semantic Scholar
A Partially-Randomised Phase 3 Trial of Pretomanid, Moxifloxacin and Pyrazinamide in Combination for the Treatment of Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis
C. Tweed, G. Wills, A. Crook, E. Amukoye +35 more
20201 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Tracy L. Dalton×9
Invite
Tracy L. Dalton — researcher profile on SciRah
J. Ershova×9
Invite
J. Ershova — researcher profile on SciRah
B. Kazennyy×8
Invite
B. Kazennyy — researcher profile on SciRah
H. Kim×8
Invite
H. Kim — researcher profile on SciRah

×8

Invite

E. Kurbatova — researcher profile on SciRah

Invite

V. Leimane — researcher profile on SciRah

M. L. van der Walt×8

Invite

M. L. van der Walt — researcher profile on SciRah

G. Volchenkov×8

Invite

G. Volchenkov — researcher profile on SciRah

Martin J. A. Yagui×8

Invite

Martin J. A. Yagui — researcher profile on SciRah

Invite

T. Tupasi — researcher profile on SciRah

Invite

K. Kliiman — researcher profile on SciRah

Invite

L. Via — researcher profile on SciRah